110 related articles for article (PubMed ID: 12775288)
1. Hypercalcemia upon recurrence of renal cell carcinoma producing parathyroid hormone-related protein.
Ueno M; Tokonabe S; Kuroda I; Tsukamoto T; Deguchi N
Scand J Urol Nephrol; 2003; 37(3):265-8. PubMed ID: 12775288
[TBL] [Abstract][Full Text] [Related]
2. Denosumab for the treatment of bisphosphonate-refractory hypercalcemia.
Boikos SA; Hammers HJ
J Clin Oncol; 2012 Oct; 30(29):e299. PubMed ID: 22949145
[No Abstract] [Full Text] [Related]
3. Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Br J Cancer; 1994 Jul; 70(1):169-72. PubMed ID: 8018531
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia in a patient with renal cell carcinoma producing parathyroid hormone-related protein and interleukin-6.
Ueno M; Ban S; Nakanoma T; Tsukamoto T; Nonaka S; Hirata R; Iida M; Deguchi N
Int J Urol; 2000 Jun; 7(6):239-42. PubMed ID: 10843457
[TBL] [Abstract][Full Text] [Related]
5. [PTHrP and breast cancer].
Devys A; Lortholary A; Audran M
Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801
[TBL] [Abstract][Full Text] [Related]
6. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related protein and serum calcium in patients with renal cell carcinoma.
Papworth K; Grankvist K; Ljungberg B; Rasmuson T
Tumour Biol; 2005; 26(4):201-6. PubMed ID: 16006777
[TBL] [Abstract][Full Text] [Related]
8. Hypercalcemia in patients with metastatic renal cell carcinoma: effect of nephrectomy and metabolic evaluation.
Walther MM; Patel B; Choyke PL; Lubensky IA; Vocke CD; Harris C; Venzon D; Burtis WJ; Linehan WM
J Urol; 1997 Sep; 158(3 Pt 1):733-9. PubMed ID: 9258070
[TBL] [Abstract][Full Text] [Related]
9. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
10. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
Blind E; Raue F; Meinel T; Wüster C; Ziegler R
Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
[TBL] [Abstract][Full Text] [Related]
11. [Effect of pamidronate and interferon-alpha on bone and lung metastases and hypercalcemia in a patient with renal cell carcinoma].
Kise H; Kobayashi K; Arima K; Yanagawa M; Tochigi H; Kawamura J; Hioki T; Sugiura Y
Hinyokika Kiyo; 1996 Nov; 42(11):879-81. PubMed ID: 8973939
[TBL] [Abstract][Full Text] [Related]
12. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukin-6 in the induction of hypercalcemia in renal cell carcinoma transplanted into nude mice.
Weissglas MG; Schamhart DH; Löwik CW; Papapoulos SE; Theuns HM; Kurth KH
Endocrinology; 1997 May; 138(5):1879-85. PubMed ID: 9112382
[TBL] [Abstract][Full Text] [Related]
14. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
15. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul MC
Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953
[No Abstract] [Full Text] [Related]
16. Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis.
Wysolmerski JJ; Dann PR; Zelazny E; Dunbar ME; Insogna KL; Guise TA; Perkins AS
J Bone Miner Res; 2002 Jul; 17(7):1164-70. PubMed ID: 12096830
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein.
Papapetrou PD; Bergi-Stamatelou M; Karga H; Thanou S
Eur J Endocrinol; 2003 Mar; 148(3):351-5. PubMed ID: 12611617
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two immunoradiometric assays for parathyroid hormone-related protein in the evaluation of cancer patients with and without hypercalcemia.
de Miguel F; Motellón JL; Hurtado J; Jiménez FJ; Esbrit P
Clin Chim Acta; 1998 Oct; 277(2):171-80. PubMed ID: 9853700
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.
Shivnani SB; Shelton JM; Richardson JA; Maalouf NM
Endocr Pract; 2009 Apr; 15(3):234-9. PubMed ID: 19364692
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas.
Mitlak BH; Hutchison JS; Kaufman SD; Nussbaum SR
Horm Metab Res; 1991 Jul; 23(7):344-6. PubMed ID: 1663481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
